XML 53 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Common Stock Compensation
 6 Months Ended
Dec. 31, 2019
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Common Stock Compensation

 

(10) Common Stock Compensation

 

Stock Option Activity Summary

 

The Company’s stock option activity for the six months ended December 31, 2019, is as follows:

 

 

 

Shares

(in thousands)

 

 

Weighted Average

Exercise Price

 

Outstanding at June 30, 2019

 

 

324

 

 

$

5.71

 

Granted

 

 

10

 

 

 

1.85

 

Exercised

 

 

—

 

 

 

—

 

Canceled or expired

 

 

(1

)

 

 

5.30

 

Outstanding at December 31, 2019

 

 

333

 

 

$

5.64

 

 

The aggregate intrinsic value of options exercisable at December 31, 2019, was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $76 thousand related to stock options will be recognized over a weighted-average period of 1.03 years.

 

The table below details the Company’s stock options outstanding as of December 31, 2019:

 

Range of exercise prices

 

Number

Outstanding

 

 

Options

Outstanding

Weighted-

Average

Remaining

Contractual

Life (years)

 

 

Weighted-

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Options

Exercisable

Weighted-

Average

Exercise

Price

 

$1.85 – 3.55

 

 

80,500

 

 

 

3.38

 

 

$

3.39

 

 

 

70,500

 

 

$

3.39

 

$5.30 – 5.85

 

 

122,319

 

 

 

7.36

 

 

 

5.48

 

 

 

79,575

 

 

 

5.48

 

$6.00 – 8.35

 

 

130,000

 

 

 

4.89

 

 

 

7.19

 

 

 

86,000

 

 

 

6.59

 

$1.85 – 8.35

 

 

332,819

 

 

 

5.43

 

 

$

5.64

 

 

 

236,075

 

 

$

5.26

 

 

Compensation costs recognized related to stock option awards were $41 thousand and $43 thousand for the three months ended December 31, 2019 and 2018, respectively, and $85 thousand and $84 thousand for the six months ended December 31, 2019 and 2018, respectively.

 

Restricted Stock

 

The Company’s restricted stock activity for the six months ended December 31, 2019, is as follows:

 

 

 

Shares

(in thousands)

 

 

Weighted

Average

Grant-Date

Fair Value

 

Outstanding at June 30, 2019

 

 

208

 

 

$

4.06

 

Granted

 

 

5

 

 

 

2.47

 

Vested

 

 

(62

)

 

 

3.74

 

Canceled or expired

 

 

(11

)

 

 

3.99

 

Outstanding at December 31, 2019

 

 

140

 

 

$

3.97

 

 

Stock compensation expenses related to restricted stock were $42 thousand and $19 thousand for the three months ended December 31, 2019 and 2018, respectively, and $102 thousand and $14 thousand for the six months ended December 31, 2019, and 2018, respectively. The remaining stock-based compensation expense of $411 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 1.99 years.